AlanBreierMD
Neurology • Indianapolis, INProfessor of Psychiatry and assumed respoinsibilities as Chief of the Psychotic Disorders Program and Director of Research at Larue Carter hospital
Are you Dr. Breier?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
355 W 16th St
Ste 2800
Indianapolis, IN 46202Phone+1 317-963-7300Fax+1 317-943-7325
Summary
- Dr. Alan Breier, MD is a board certified neurologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, District of Columbia, and Maryland. He is affiliated with Eskenazi Health.
Education & Training
National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1987
Yale-New Haven Medical CenterResidency, Psychiatry, 1981 - 1984- Yale-New Haven Medical CenterInternship, Transitional Year, 1980 - 1981
University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
IN State Medical License 1997 - 2025
MD State Medical License 1984 - 1998
DC State Medical License 1990 - 1997- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects Start of enrollment: 2008 Sep 01
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone Start of enrollment: 2010 Jul 01
- The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- Robust Brain Correlates of Cognitive Performance in Psychosis and Its Prodrome.Heather Burrell Ward, Adam Beermann, Jing Xie, Gulcan Yildiz, Karlos Manzanarez Felix
Biological Psychiatry. 2025-01-15 - 5 citationsMuscarinic Receptor Activators as Novel Treatments for Schizophrenia.Steven M Paul, Samantha E Yohn, Stephen K Brannan, Nichole M Neugebauer, Alan Breier
Biological Psychiatry. 2024-10-15 - Altered Vesicular Acetylcholine Transporter Availability in Schizophrenia: Association With Positive Symptoms and Cognitive Impairment.Samantha E Yohn, Alan Breier, Steven M Paul
Biological Psychiatry. 2024-09-01
Press Mentions
The Inside Story of CobenfyOctober 3rd, 2024- BTAI: Highlights from BXCL501 KOL Event…February 25th, 2021
BioXcel Therapeutics Forms Neuroscience Clinical Advisory Board to Support Global Development of BXCL501July 10th, 2018- Join now to see all
